Investigators: Jeffrey M Statland MD, Rabi Tawil MD
Category: Research - Clinical
The primary goal of this proposal is to hasten therapeutic development for FSHD and improve care delivery by creating a standard clinic-based protocol informed by best practice guidelines to determine the predictive value of clinical characteristics and motor assessments on motor and health outcomes (i.e. need for orthotics, ambulation aides, respiratory support, etc.) – this will help us understand how large a change in outcome assessments would be clinically meaningful, and help us know what baseline FSHD characteristics predict future motor or health outcomes.
One year no-cost extension granted 8-May-2023 (9-Jul-2023 to 31-Jul-2024).
One year no-cost extension granted 31-Aug-2024 (31-Jul-2024 to 31-Jul-2025) & budget changes.
Related Material
Grant Information
Date awarded: Jul 10, 2020
End date: Jul 31, 2025
Amount awarded: $327,145
University of Kansas Medical Center
Jeffrey M Statland MD
Assistant Professor
University of Kansas Medical Center
Rabi Tawil MD
Professor of Neurology
University of Rochester
Connect with us on social media